$2.15 Billion Spatial Genomics and Transcriptomics Markets – Global Opportunities Analysis and Industry Forecast, 2021-2030

DUBLIN, April 29, 2022–(BUSINESS WIRE)–The “Space Genomics and Transcriptomics Market by Technique, Product Type, Application, and End-User: Global Opportunity Analysis and Industry Forecast, 2021-2030” report has been added to from ResearchAndMarkets.com offer.

The global Spatial Genomics and Transcriptomics Market size was valued at USD 0.62 Billion in 2020 and is projected to reach USD 2.15 Billion by 2030, registering a CAGR of 13.6% from 2021 to 2030 .

Spatial genomics & transcriptomics is a new discipline involving the identification of powerful information regarding the organizational composition of tissues and cellular content. It is a method that uses mRNA reads to assign cell types to their positions in histological sections. This method can also be used to determine subcellular localization and cellular heterogeneity of mRNA molecules in cancers and organs.

In addition, spatial genomics and transcriptomics provide information about immune cells and characterize the subcellular distribution of transcripts in various situations. Spatial genomics has a lot of potential in disease control as it provides quantitative data on gene expression as well as visualization mapping of DNA and RNA in tissue components. Furthermore, sequencing techniques play an important role in spatial transcriptomics, due to the widespread availability of sequencing platforms that facilitate the study of RNA architecture in cells or tissues, as well as the use of advanced techniques in a laboratory setting to study biological organisms.

Major factors that are impacting the growth of the Spatial Genomics and Transcriptomics market include increasing adoption of Spatial Genomics and Transcriptomics technologies, owing to their various applications. Additionally, the growth in the prevalence of genetic disorders and the applications of spatial genomics and transcriptomics in determining disease and treatment markers are also driving the market growth. Moreover, increasing preference for personalized drugs is also fueling the growth of the market.

However, unavailability of skilled professionals and ethical and legal limitations associated with the use of spatial genomics and transcriptomic technologies are hampering the growth of the market. On the other hand, growth in innovations in spatial genomics and transcriptomics technologies are expected to provide profitable opportunities for market growth over the forecast period.

COVID-19 is a large family of viruses that causes illnesses ranging from the common cold to more serious respiratory illnesses. The global spatial genomics and transcriptomics market also declined in 2020 owing to the global economic downturn caused by COVID-19. However, the recovery of market witnesses in 2021, owing to the increase in the adoption of spatial genomics and transcriptomics to profile COVID-19 tissue autopsies, as well as the increase in the identification of biomarkers and their use in drug discovery and development programs.

The global spatial genomics and transcriptomics market is segmented on the basis of technique, product type, application, end-user, and region. By technique, it is divided into spatial transcriptomics and spatial genomic analysis. The spatial transcriptomics are then segmented into microdissection, fluorescent in situ hybridization, in situ sequencing, in situ capture and in silico construction.

Additionally, the spatial genomic analysis segment is segmented into fluorescence in situ sequencing and fluorescence microscopy. The spatial genomic analysis segment was the largest shareholder in 2020, due to the emerging potential of spatial genomic analysis as a cancer diagnostic tool and the advent of fourth generation sequencing.

By product type, it is segmented into instruments, consumables and software. The consumables segment dominated the global spatial genomics and transcriptomics market in 2020 and is expected to continue this trend during the forecast period. This is attributed to the increased adoption of consumables needed to operate the instruments at different stages of genome mapping, from sample preparation to result derivation. Based on application, it is segmented into translational research and drug discovery and development.

Drug discovery and development acquired the largest share in 2020 and is expected to remain dominant throughout the forecast period. This is attributed to the increasing application of spatial genomics and transcriptomics technologies in drug discovery and development. By end-user, it is segmented into pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes.

The academic and research institute segment acquired the largest share in 2020 and is expected to continue this trend during the forecast period. This is attributed to the increase in genomic research projects conducted by academic research institutes as well as the collaboration between major players and universities for the development of new approaches to cure chronic diseases through genetic medicine.

Main results of the study

  • Based on the technique, spatial genomic analysis held the largest global market share in 2020

  • Based on product type, consumables held the largest spatial genomics and transcriptomics market share in 2020 and are expected to remain dominant throughout the forecast period

  • By application, drug discovery and development is dominating the global spatial genomics and transcriptomics market in 2020 and is expected to continue this trend during the forecast period

  • By end-user, academic and research institutes held the largest market share in 2020 and are expected to continue this trend during the forecast period

  • By region, North America is expected to witness the highest growth, registering a CAGR of 106% during the forecast period

  • North America accounted for the largest share of the global spatial genomics and transcriptomics market in 2020 and is expected to remain dominant throughout the forecast period. This has been attributed to the presence of a large number of key players as well as the increase in the number of large-scale genomic studies leveraging RNA sequencing in the region. Furthermore, the increasing adoption of personalized medicine for the screening and diagnosis of genetic disorders is expected to further boost the market. growth

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • 10X Genomics, Inc.

  • Akoya Biosciences, Inc.

  • Bio Spyder Technologies Inc.

  • Bio-Techne Corporation (Advanced Cell Diagnostics, Inc)

  • Dovetail Genomics, LLC

  • Fluidigm Company

  • Genomic Vision SA

  • Illumina, Inc.

  • Lunaphore Technologies SA

  • Nanostring Technologies, Inc.

  • Natera inc.

  • PerkinElmer Inc (Horizon Discovery Group Plc)

  • Rarecyte, Inc.

  • Rebus Biosystems, LLC

  • Solving Biosciences

  • S2 Genomics

  • Seven Bridges Genomics

  • Singular Genomics System, Inc

  • Tecan Group Ltd (Nugen Technologies, Inc)

  • Ultivue, Inc.

  • Veranome Biosystems LLC

  • Vizgen Corporation

KEY MARKET SEGMENTS

By technique

  • Spatial transcriptomics

  • Microdissection

  • Fluorescent in-situ hybridization

  • In situ sequencing

  • In-situ capture

  • In-silico construction

  • Spatial genomic analysis

  • In-situ sequencing by fluorescence

  • Fluorescence microscopy

By product type

  • Instruments

  • Consumables

  • Software

By app

Per end user

  • Pharmaceutical and biotechnology companies

  • Contract research organizations

  • Academic and research institutes

By region

  • North America

  • WE

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • The rest of Europe

  • Asia Pacific

  • Japan

  • China

  • Australia

  • India

  • South Korea

  • Rest of Asia-Pacific

  • LAMEA

  • Latin America

  • Middle East and Africa

For more information on this report, visit https://www.researchandmarkets.com/r/avh6t0

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220429005281/en/

contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Officer
press@researchandmarkets.com
For EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900

Leave a Reply

Your email address will not be published.